RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,004,653 | +488.0% | 436,408 | +323.0% | 0.00% | – |
Q2 2023 | $1,701,454 | -56.0% | 103,181 | -52.4% | 0.00% | – |
Q1 2023 | $3,864,519 | -45.5% | 216,621 | -11.1% | 0.00% | -100.0% |
Q4 2022 | $7,096,107 | +25.8% | 243,685 | +5.9% | 0.00% | 0.0% |
Q3 2022 | $5,639,000 | +215.4% | 230,197 | -46.6% | 0.00% | – |
Q2 2022 | $1,788,000 | -39.2% | 430,747 | +68.6% | 0.00% | – |
Q1 2022 | $2,943,000 | +9.9% | 255,492 | -4.8% | 0.00% | – |
Q4 2021 | $2,678,000 | -0.2% | 268,363 | +30.6% | 0.00% | – |
Q3 2021 | $2,684,000 | -69.3% | 205,466 | -54.0% | 0.00% | -100.0% |
Q2 2021 | $8,744,000 | +307.6% | 446,606 | +342.8% | 0.00% | – |
Q1 2021 | $2,145,000 | +43.7% | 100,849 | +100.9% | 0.00% | – |
Q4 2020 | $1,493,000 | +339.1% | 50,206 | +220.2% | 0.00% | – |
Q3 2020 | $340,000 | -38.0% | 15,679 | -36.1% | 0.00% | – |
Q2 2020 | $548,000 | +224.3% | 24,551 | +121.2% | 0.00% | – |
Q1 2020 | $169,000 | -87.5% | 11,100 | -81.1% | 0.00% | – |
Q4 2019 | $1,352,000 | +393.4% | 58,874 | +362.2% | 0.00% | – |
Q3 2019 | $274,000 | +585.0% | 12,739 | +588.2% | 0.00% | – |
Q2 2019 | $40,000 | -68.5% | 1,851 | -59.8% | 0.00% | – |
Q1 2019 | $127,000 | -81.6% | 4,609 | -82.0% | 0.00% | – |
Q4 2018 | $689,000 | -11.3% | 25,614 | -3.9% | 0.00% | – |
Q3 2018 | $777,000 | -16.2% | 26,652 | -10.1% | 0.00% | – |
Q2 2018 | $927,000 | +177.5% | 29,646 | +76.7% | 0.00% | – |
Q1 2018 | $334,000 | -56.9% | 16,780 | -37.0% | 0.00% | – |
Q4 2017 | $775,000 | – | 26,647 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |